Treatment
Comparator clinical trials
We’re tracking 1,699 recruiting studies that include Comparator, each written for real people, not researchers, below.
Recruiting studies
- NCT07757087RecruitingPhase 1
Study on energy use after weight loss
This study tests a new medicine to see how it affects the body's energy use after losing weight. It compares the medicine to a low-calorie diet or a placebo (a pill with no active ingredient) in adults with obesity.
Aarhus NAges 18 years+ - NCT07755410RecruitingPhase 2
Investigational ADHD treatment for adults
This study tests an investigational medication for adults with attention deficit hyperactivity disorder (ADHD). It aims to see if this new drug helps reduce ADHD symptoms compared to a placebo.
Little Rock, ArkansasAges 18–65 - NCT07752407RecruitingPhase 3
Heartburn relief study for people with non-erosive GERD
This study tests a new medicine called vonoprazan to see if it can reduce episodes of heartburn in people who have GERD but no damage to their esophagus. It compares the medicine to a placebo (a pill with no active ingredient) over 24 weeks.
Mentor, OhioAges 18 years+ - NCT07753993RecruitingPhase 3
Study of elecoglipron for chronic kidney disease
This trial tests an investigational medicine called elecoglipron for people with chronic kidney disease. It aims to see if it can improve kidney health compared to a placebo (inactive pill) and may be an option for those already on standard blood pressure and kidney protective medications.
Huntsville, AlabamaAges 18 years+ - NCT07755956RecruitingPhase 1
Study of a new injection for endometriosis pain
This study tests a new medicine called HHK001 for endometriosis. It is compared with a standard treatment (Enantone) to see if it is safe and works well to reduce symptoms.
Changsha, HunanAges 18–45 - NCT07751250RecruitingPhase 1
Casdatifan in moderate liver impairment
This study looks at how a new drug, casdatifan, is processed in the body in people with moderate liver problems compared to healthy people. Understanding this helps doctors decide if the drug is safe and how to dose it for patients with liver issues.
San Antonio, TexasAges 18–84 - NCT06527560RecruitingPhase 4
Comparing oral vs. IV cefuroxime for kidney infection in pregnancy
This study compares a pill form of the antibiotic cefuroxime to an IV (intravenous) version for treating kidney infections during pregnancy. It aims to see if the oral option works just as well, which could make treatment easier and more comfortable for pregnant women.
Porto Alegre, Rio Grande do SulAges 18–48 - NCT07740824Recruiting
Oral supplement for healthier, younger-looking skin
This study tests an oral supplement to see if it improves signs of facial skin aging in healthy adults. Participants take the supplement daily for 8 weeks and undergo two small skin biopsies on the upper arms to measure changes.
Bangalore, KarnatakaAges 35–65 - NCT07746726RecruitingPhase 3
Comparing two muscle relaxants for breathing tube placement during surgery
This study compares a new muscle relaxant medication with a standard one to see how well they work for placing a breathing tube and maintaining muscle relaxation during surgery. It aims to find a safer or more effective option for patients undergoing general anesthesia.
Changsha, HunanAges 18–75 - NCT07742735RecruitingPhase 3
Study of apraglutide for short bowel syndrome with intestinal failure
This study tests a new medicine called apraglutide, given as a shot, to see if it can help adults with short bowel syndrome and intestinal failure reduce their need for intravenous nutrition (parenteral support). The study compares apraglutide to a placebo (a shot with no medicine) to check if it is safe and effective.
Los Angeles, CaliforniaAges 18 years+ - NCT07745504RecruitingPhase 3
Comparing two versions of a new weight-loss medication
This study compares two different versions of an investigational weight-loss medication (cagrilintide) against a placebo to see which is more effective and safe for people with excess weight. Participation involves receiving injections and regular check-ins to monitor your progress.
Conyers, GeorgiaAges 18 years+ - NCT07745127Recruiting
Nasal stitch versus packing after nose surgery
This study compares two ways to stop bleeding after nasal surgery (septoplasty): using a special stitch inside the nose versus using nasal packing. It aims to see which method is more comfortable and effective for patients like you.
Islamabad, FedralAges 18–50 - NCT07745673Recruiting
Study of targeted treatment for Parkinson's disease symptoms
This study compares different ways of targeting treatment for Parkinson's disease symptoms. It is designed for people with mild to moderate Parkinson's who have had symptoms for at least 2 years and are generally stable on their current medications.
Wuhan, HubeiAges 40 years+ - NCT07745426RecruitingPhase 2
Comparing add-on treatments for rheumatoid arthritis
This trial compares two additional medicines (diosmin or rebamipide) taken with standard arthritis treatment to see if they help reduce joint pain and swelling better than standard treatment alone.
TantaAges 18–70 - NCT06238648RecruitingPhase 2
Epcoritamab for B-cell lymphoma after CAR-T therapy
This trial tests if the drug epcoritamab can help people with B-cell lymphoma whose cancer showed only a partial response 30 days after CAR-T cell therapy. It compares epcoritamab to simply monitoring the condition.
Rochester, MinnesotaAges 18 years+ - NCT06623123RecruitingPhase 3
Phone app vs. talking therapy for tinnitus relief
This trial compares a smartphone app called Oto to standard talking therapies for treating tinnitus. If you have had tinnitus for at least 3 months and can use an app, this study may help you find relief.
Stevenage, HertfordshireAges 18 years+ - NCT07733830RecruitingPhase 2
Testing immunotherapy before or after chemoradiation for advanced esophageal cancer
This trial compares two treatment sequences for people with locally advanced esophageal cancer that cannot be removed with surgery. One group gets immunotherapy first, then chemoradiation; the other gets chemoradiation first, then immunotherapy. The goal is to find which order works better.
Beijing, Beijing MunicipalityAges 18–75 - NCT07733024RecruitingPhase 2
Comparing a new DLL3 PET/CT scan to standard scans for neuroendocrine cancer
This study tests a new type of PET/CT scan that looks for a marker called DLL3 on neuroendocrine cancer cells. It aims to see if this scan finds tumors better than standard scans, which could help guide treatment.
Beijing, Beijing MunicipalityAges 18–80 - NCT07740148Recruiting
Comparing feelings about human-created and AI art
This study compares how people feel when looking at art made by humans versus art made by artificial intelligence (AI). You'll view images online and answer questions about your reactions, helping researchers understand emotional responses to different types of art.
Palo Alto, CaliforniaAges 18 years+ - NCT07740382Recruiting
Pain block comparison for recovery after liver surgery
This study compares two types of pain-relieving nerve blocks used during liver surgery to see which one helps you breathe better and recover more comfortably after the operation.
Alexandria, Sbein-ElkomAges 18–75 - NCT07734844RecruitingPhase 3
New vs existing treatment for diabetic macular edema
This study compares a new medication, tabirafusp tedromer, to an existing treatment, aflibercept, for people with diabetic macular edema (swelling in the back of the eye from diabetes). It may help if your DME hasn't improved or you're looking for a new option.
Glendale, CaliforniaAges 18 years+ - NCT06395246Recruiting
Weight loss and tiny cell particles study
This study looks at how weight loss from a special diet affects tiny particles in your blood, called microvesicles, that help control your body's energy use. It may help us understand why weight loss improves health for people with obesity.
Tarragona, TarragonaAges 18–70 - NCT06625424Recruiting
Short sprints with active recovery for non-athletes
This study tests whether doing very short, all-out sprints with active recovery (like walking or light jogging) improves your body's ability to perform high-intensity exercise better than resting between sprints. It is for healthy young adults who are not competitive athletes.
Rawalpindi, Punjab ProvinceAges 18–25 - NCT07728539Recruiting
Comparing a faster ablation method for atrial fibrillation
This study compares a newer, faster type of ablation (high-power short-duration) with the standard approach for treating atrial fibrillation. The goal is to see which method is safer and more effective at restoring a normal heart rhythm.
MoscowAges 18–70
Common questions
- Are there clinical trials studying Comparator?
- Yes. Clin2 currently lists 1,699 recruiting studies that include Comparator, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Comparator trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Comparator an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Comparator or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.